Holen Sie sich die Stockscreener-App
153.49
2.49%
3.73
Vorhandelsmarkt:
151.89
-1.60
-1.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina stock target lifted amid strong margins and consumables drive growth - Investing.com
Illumina revenue dips 2% to USD 1.1 billion for Q3 2024 - Medical Buyer
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Van ECK Associates Corp - MarketBeat
Bioinformatics Market Forecasted to Reach $29.1 Billion by 2031 | Illumina Inc., Thermo Fischer Scientific, Qiagen NV - openPR
Earnings call: Illumina reports mixed Q3 results, plans for future growth - Investing.com
Vanguard Group Inc's Strategic Acquisition of Illumina Inc Shares - GuruFocus.com
Illumina Introduces the MiSeq i100 Series - MPO-mag
Illumina Reports Q3 2024 Financial Results Amid Strategic Expansion - TipRanks
Illumina (ILMN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - TradingView
Illumina: Q3 Earnings Snapshot - San Antonio Express-News
Illumina (NASDAQ:ILMN) Updates FY 2024 Earnings Guidance - MarketBeat
Illumina stock falls 6% amid lowered 2024 revenue guidance - MSN
Illumina stock falls 6% amid lowered 2024 revenue guidance (NASDAQ:ILMN) - Seeking Alpha
Illumina shares fall 5% as Q4 revenue guidance disappoints By Investing.com - Investing.com Nigeria
Illumina shares fall 5% as Q4 revenue guidance disappoints - Investing.com
Illumina, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2024 - Marketscreener.com
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024 - PR Newswire
Illumina (NASDAQ:ILMN) Hits New 12-Month HighStill a Buy? - MarketBeat
Illumina Inc (ILMN) Trading 3.49% Higher on Nov 4 - GuruFocus.com
Enabling single-cell sequencing for every laboratory - Illumina
Illumina stock soars to 52-week high, reaches $152.12 - Investing.com
Illumina to present updates on several key innovations in whole-genome sequencing at ASHG meeting - The Financial Express
Illumina Q3 24 Earnings Conference Call At 4:30 PM ET - Nasdaq
Epigenetics Market Types and Applications, Drivers, Ongoing - openPR
At ASHG, Illumina to Share Updates to Sequencing, Proteomics, and Single-Cell Technologies - Genetic Engineering & Biotechnology News
Argonautica Private Wealth Management Inc. Takes $569,000 Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by New York State Teachers Retirement System - MarketBeat
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
NXP, Illumina, Vertex set to report earnings Monday By Investing.com - Investing.com Australia
NXP, Illumina, Vertex set to report earnings Monday - Investing.com
Stephens Investment Management Group LLC Has $28.01 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting - PR Newswire
Illumina Leads the Way With Its Steps Against Cancer Campaign - ReportAlert.info
Hudson Valley Investment Advisors Inc. ADV Boosts Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
What Analyst Projections for Key Metrics Reveal About Illumina (ILMN) Q3 Earnings - MSN
Comprehensive Study of Microfluidic Market 2024-2031 Trends, - openPR
Celebrating Diwali in India for the first time in 20 years - Illumina
Illumina leads the way with its Steps Against Cancer campaign - Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Deltec Asset Management LLC - MarketBeat
(ILMN) Trading Report - Stock Traders Daily
Strategic Buy Lights Up This Biotech Stock: Time to Invest? - MSN
Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
Illumina's Q3 Earnings Coming Up: Time to Buy, Sell or Hold the Stock? - MSN
Microbiome Diagnostics Market to hit USD 429.2 million by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
The Emerging Population Genomics Revolution - ReportAlert.info
The emerging population genomics revolution - Illumina
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Mirae Asset Global Investments Co. Ltd. Boosts Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina (ILMN) Set to Announce Quarterly Earnings on Monday - MarketBeat
DNA Microarray Global Market Rising Trends, Industry Size, - openPR
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Illumina's SWOT analysis: stock outlook amid sequencing market shifts - Investing.com India
Illumina's SWOT analysis: stock outlook amid sequencing market shifts By Investing.com - Investing.com South Africa
DNA Microarray Market Analysis: Segments, Drivers, - openPR
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers - The Manila Times
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zurich lab imagines new possibilities in microbial research and diagnostics - Illumina
Cancer Biomarkers Industry Analysis and Market Opportunities, Forecast to 2029A Forecasted $42 Billion Landscape, Dominated by Roche, Thermo Fisher Scientific, QIAGEN, Illumina, and Bio-Rad Labs - GlobeNewswire
Illumina launches next-gen benchtop sequencers with sustainable and comprehensive approach - BSA bureau
SG Americas Securities LLC Sells 22,245 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Raymond James & Associates Raises Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
0.03%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):